FDA Approves New Indication for ENVARSUS XR® (tacrolimus extended-release tablets)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. OSIS
9. BJ
10. ANF

Go back to FDA Approves New Indication for ENVARSUS XR® (tacrolimus extended-release tablets)
(NASDAQ: VELO) Delayed: 13.29 +0.12 (0.91%)
Previous Close $13.17    52 Week High $ 
Open $13.38    52 Week Low $ 
Day High $13.75    P/E N/A 
Day Low $12.71    EPS $ 
Volume 506,651